Medtronic PLC (MDT)
81.12
+0.88
(+1.10%)
USD |
NYSE |
May 01, 14:15
Medtronic Net Income (Quarterly): 1.322B for Jan. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.322B |
| October 31, 2023 | 909.00M |
| July 31, 2023 | 791.00M |
| April 30, 2023 | 1.179B |
| January 31, 2023 | 1.222B |
| October 31, 2022 | 427.00M |
| July 31, 2022 | 929.00M |
| April 30, 2022 | 1.485B |
| January 31, 2022 | 1.48B |
| October 31, 2021 | 1.311B |
| July 31, 2021 | 763.00M |
| April 30, 2021 | 1.36B |
| January 31, 2021 | 1.27B |
| October 31, 2020 | 489.00M |
| July 31, 2020 | 487.00M |
| April 30, 2020 | 646.00M |
| January 31, 2020 | 1.915B |
| October 31, 2019 | 1.364B |
| July 31, 2019 | 864.00M |
| April 30, 2019 | 1.172B |
| January 31, 2019 | 1.269B |
| October 31, 2018 | 1.115B |
| July 31, 2018 | 1.075B |
| April 30, 2018 | 1.46B |
| January 31, 2018 | -1.389B |
| Date | Value |
|---|---|
| October 31, 2017 | 2.017B |
| July 31, 2017 | 1.016B |
| April 30, 2017 | 1.163B |
| January 31, 2017 | 821.00M |
| October 31, 2016 | 1.115B |
| July 31, 2016 | 929.00M |
| April 30, 2016 | 1.103B |
| January 31, 2016 | 1.095B |
| October 31, 2015 | 520.00M |
| July 31, 2015 | 820.00M |
| April 30, 2015 | -1.00M |
| January 31, 2015 | 977.00M |
| October 31, 2014 | 828.00M |
| July 31, 2014 | 871.00M |
| April 30, 2014 | 448.00M |
| January 31, 2014 | 762.00M |
| October 31, 2013 | 902.00M |
| July 31, 2013 | 953.00M |
| April 30, 2013 | 969.00M |
| January 31, 2013 | 988.00M |
| October 31, 2012 | 646.00M |
| July 31, 2012 | 864.00M |
| April 30, 2012 | 991.00M |
| January 31, 2012 | 935.00M |
| October 31, 2011 | 871.00M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
427.00M
Minimum
Oct 2022
1.915B
Maximum
Jan 2020
1.064B
Average
1.179B
Median
Apr 2023
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 1.225B |
| Boston Scientific Corp | 494.00M |
| Stryker Corp | 1.143B |
| Axonics Inc | 6.574M |
| Conmed Corp | 19.71M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.089B |
| Total Expenses (Quarterly) | 6.586B |
| EPS Diluted (Quarterly) | 0.99 |
| Enterprise Value | 123.55B |
| Gross Profit Margin (Quarterly) | 65.61% |
| Profit Margin (Quarterly) | 16.34% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 5.68% |
| Normalized Earnings Yield | 4.200 |